Researchers have shown that a controversial phenomenon known as antibody-dependent enhancement of infection is suppressed by C1q, a blood-borne immune system compound. The link may give researchers the lead they need to begin untangling a snarl of evidence from decades of puzzling epidemiological and laboratory-based studies of ADE.
More...